Amazon Drugs Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 37 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.80 M
- Revenue Growth 26.99%
- Profit Growth 93.64%
- Ebitda 104.74%
- Net Worth 3.30%
- Total Assets 1.80%
About Amazon Drugs
Amazon Drugs Private Limited (ADPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 September 1987 and has a history of 37 years and five months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹6.80 M.
Tej Krishen and Deepak Sadhu serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U02423KA1987PTC008556
- Company No.
008556
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 1987
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Amazon Drugs Private Limited offer?
Amazon Drugs Private Limited offers a wide range of products and services, including Card Holder & Cases, Leather Card Holders, Leather Bags, Leather Luggage Bag, Ladies Leather Bag.
Who are the key members and board of directors at Amazon Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tej Krishen  | Managing Director | 03-Sep-1987 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Sadhu | Director | 22-Mar-2013 | Current |
Financial Performance of Amazon Drugs.
Amazon Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.99% increase. The company also saw a substantial improvement in profitability, with a 93.64% increase in profit. The company's net worth moved up by a moderate rise of 3.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amazon Drugs?
In 2019, Amazon Drugs had a promoter holding of 22.57% and a public holding of 77.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.80 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Mysore : 0.35 Cr
- M/S Karnataka State Financial Corporation : 0.24 Cr
- Jammu & Kashmir Bank Ltd. : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Nov 2006 | State Bank Of Mysore | ₹3.50 M | Open |
| 28 Mar 1994 | Jammu & Kashmir Bank Ltd. | ₹0.90 M | Open |
| 07 Sep 1992 | M/S Karnataka State Financial Corporation | ₹2.40 M | Open |
How Many Employees Work at Amazon Drugs?
Amazon Drugs has a workforce of 2 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amazon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amazon Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
